Quality and Regulatory at the Speed of AI: Moving Faster Without Losing Trust

Bryan Gilpin, President, Suntra MedTech Solutions

Bryan has spent his career building and growing great organizations to
deliver technology that improves lives around the world. His passion for
healthcare has led him to lead large-scale teams at Fortune 500 companies and foster innovation in smaller, high-growth startups. Bryan holds an MSEE and an MBA from MIT and a BS in Computer Engineering from the University of Illinois. He loves traveling, running and spending time with his wife and two daughters.

Topaz Kirlew, D.B.A, Corporate VP and Chief Regulatory Officer, Integra LifeSciences

Topaz Kirlew is the corporate vice president and chief regulatory officer at Integra LifeSciences. She is responsible for leading global regulatory strategy and activities in support of the company’s strategic priorities.
With more than 35 years of industry experience, Topaz has deep expertise in regulatory affairs, compliance, clinical trials, quality systems, manufacturing operations, and strategic planning across the medical device, biologics, drug, human tissue, cell therapy, and transfusion medicine industries. Her leadership philosophy, grounded in empowerment, excellence, and integrity, fosters a culture where teams can learn, collaborate, and thrive.

Topaz began her career as a clinical laboratory scientist in hospitals including the National Institutes of Health (NIH), Georgetown University Hospital, and University of Maryland Medical Center. She later held positions of increasing responsibility leading Quality, Operations, Clinical, and Regulatory organizations at Danaher Corporation, Apyx Medical, BioTissue, and University of Miami’s Diabetes Research Institute. Topaz holds a bachelor of science degree in clinical laboratory science from Florida International University, an MBA, and a Doctor of Business Administration from Nova Southeastern University’s School of Business and Entrepreneurship.

Kerri DiPietro, Corporate VP and Chief Quality Officer, Integra LifeSciences

Kerri DiPietro is the chief quality officer at Integra LifeSciences. Kerri leads our global quality organization and is responsible for driving disciplined execution of the enterprise-wide compliance master plan. She will also oversee critical quality programs, including quality operations, supplier quality, post-market surveillance, design assurance, complaint handling, and validation, all aligned with global standards.
Kerri has deep expertise in leading high-performing quality organizations, driving strategic quality and compliance initiatives, fostering an engaged and results-oriented culture, and spearheading transformative change in the medical device industry.

Prior to Integra LifeSciences, Kerri served as the senior vice president of global quality and compliance at Haemonetics, where she led the development and execution of a global quality strategy, focused on delivering excellence in product quality, regulatory compliance, and business performance. Prior to this, she was at Boston Scientific, where she held roles of increasing responsibility in R&D, operations and quality.
Kerri earned both her bachelor of science and master of science in chemical engineering from Worcester Polytechnic Institute and is a Six Sigma Black Belt.